Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-011544
Filing Date
2018-08-13
Accepted
2018-08-13 17:01:21
Documents
63
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 554657
2 ex31-1.htm EX-31.1 8311
3 ex31-2.htm EX-31.2 8388
4 ex32-1.htm EX-32.1 4712
5 ex32-2.htm EX-32.2 4898
  Complete submission text file 0001493152-18-011544.txt   3106462

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE cdxi-20180630.xml EX-101.INS 458726
7 XBRL SCHEMA FILE cdxi-20180630.xsd EX-101.SCH 42734
8 XBRL CALCULATION FILE cdxi-20180630_cal.xml EX-101.CAL 48169
9 XBRL DEFINITION FILE cdxi-20180630_def.xml EX-101.DEF 131987
10 XBRL LABEL FILE cdxi-20180630_lab.xml EX-101.LAB 310270
11 XBRL PRESENTATION FILE cdxi-20180630_pre.xml EX-101.PRE 231544
Mailing Address 2800 WOODLAWN DRIVE SUITE 129 HONOLULU HI 96822
Business Address 2800 WOODLAWN DRIVE SUITE 129 HONOLULU HI 96822 808-457-1400
CARDAX, INC. (Filer) CIK: 0001544238 (see all company filings)

EIN.: 454484428 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-181719 | Film No.: 181012975
SIC: 2834 Pharmaceutical Preparations